ArticleFrontiers in medicine2025
Single-cell sequencing reveals cellular differences and potential mechanisms in congenital pulmonary airway malformation.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Composition and Function of Decellularized Human Lung Extracellular Matrix from Congenital Pulmonary Airway Malformation.Journal of clinical medicine · 2026Article
- Asthma in Children With Congenital Lung Malformations: A Population-Based Case-Control Study.Pediatric pulmonology · 2026Article
- A closed-loop comprehensive analysis of global burden data, future projections, risk factors, and molecular mechanisms on nasopharyngeal carcinoma.International journal of surgery (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Congenital pulmonary airway malformation (CPAM) is a common fetal lung developmental abnormality whose pathological process is not fully understood. Method: Single-cell sequencing technology is a novel high-throughput method that can reveal differences between different cell types and their role in disease. Results: By analyzing single-cell sequencing data from CPAM lesion tissue and normal tissue, we found an increase in erythrocytes, plasma cells and mast cells in CPAM samples. Additionally, genes such as CCL5, NKG7, GZMB, and SCGB1A1 were highly expressed in CPAM lesion tissues. The differentially expressed genes in CPAM samples are mainly related to functions such as inflammatory response, tissue remodeling, and immune response. Moreover, analysis of the signaling pathways involved in these differentially expressed genes revealed that pathways such as lysosome, phagosome, adherens junction, focal adhesion, and protein processing in the endoplasmic reticulum may be associated with the pathological process of CPAM. Conclusion: This study provides an in-depth analysis of the cellular differences between CPAM tissues and normal tissues using single-cell sequencing technology, revealing key cell types and functions involved in the development of CPAM. These findings provide important clues for a better understanding of the pathological process of CPAM and serve as a basis for identifying potential therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.